Furthermore, NGS for tumor protein 53, SMAD4, mammalian target rapamycin, and CTNNB1 genes are useful in identifying advanced neoplasia when combined with GNAS/MAPK mutation with a sensitivity and specificity of 88% and 98%, respectively [112]. The gene discussed is SMAD4; the disease is neoplasm.